Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 217

Results For "UST"

4597 News Found

Takeda reiterates the need of equitable access to healthcare for universal impact
News | September 18, 2023

Takeda reiterates the need of equitable access to healthcare for universal impact

The Government of India continues to prioritise initiatives aimed at enhancing the accessibility and equity of health services


CAHO and PFPSF launch Patient Advisory Councils
Healthcare | September 18, 2023

CAHO and PFPSF launch Patient Advisory Councils

Patient Advisory Councils (PACs) to be set up across hospitals to make patients true partners in enhancing patient safety and improving care delivery


Sun Pharma and Pharmazz ink agreement for introducing Tyvalzi in India
News | September 15, 2023

Sun Pharma and Pharmazz ink agreement for introducing Tyvalzi in India

Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)


Eye-Q launches Johnson and Johnson’s ELITA SILK procedure in India
Hospitals | September 15, 2023

Eye-Q launches Johnson and Johnson’s ELITA SILK procedure in India

This advanced technology is specifically tailored for individuals with high power prescriptions, aiming to free the 18-35 age group from the reliance on eyeglasses


Ami Organics to supply additional API to Fermion
News | September 15, 2023

Ami Organics to supply additional API to Fermion

The product is expected to start contributing meaningfully to the revenue from FY25


Cabinet approves foreign investment of up to Rs. 9,589 crore in Suven Pharmaceuticals
Policy | September 14, 2023

Cabinet approves foreign investment of up to Rs. 9,589 crore in Suven Pharmaceuticals

The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited


Bajaj Healthcare announces receipt of EIR from USFDA
Drug Approval | September 14, 2023

Bajaj Healthcare announces receipt of EIR from USFDA

The company has received the Establishment Inspection Report (EIR) from the USFDA for the Pre-Approval Inspection (PAI) at a manufacturing site situated at Savli, Vadodara, Gujarat, with Zero 483 observations


Celanese inks agreement with the Population Council to supply its VitalDose drug delivery platform
News | September 14, 2023

Celanese inks agreement with the Population Council to supply its VitalDose drug delivery platform

The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades


Sir H. N. Reliance Foundation Hospital launches Sepsis Cart
Healthcare | September 14, 2023

Sir H. N. Reliance Foundation Hospital launches Sepsis Cart

The hospital hosted a two-day event with top internal and external faculty and medical experts